Startups channel feed

On­col­o­gy biotech Ac­cent rais­es $75M to en­ter the clin­ic

Last year
Financing

Ar­riVent out­lines plans for $135M IPO in sec­ond biotech list­ing of 2024

Last year
Financing
China

Dew­point Ther­a­peu­tics re­struc­tures to ‘make room’ for en­try in­to the clin­ic next year in on­col­o­gy, ALS

Last year
People

Graphite Bio co-founder de­buts Treg cell ther­a­py start­up with $75M, aims to ‘trick’ im­mune sys­tem in­to re­set­ting

Last year
Financing
Cell/Gene Tx

Ra­tio rais­es $50M as ra­dio­phar­ma field finds its groove

Last year
Financing

Jaguar Gene Ther­a­py spins out man­u­fac­tur­ing with Deer­field, ARCH sup­port

Last year
Cell/Gene Tx
Manufacturing

Co­manche se­cures $75M to test preeclamp­sia siR­NA in PhII, adds Scott Got­tlieb to board

Last year
Financing

Kyver­na Ther­a­peu­tics files for IPO as au­toim­mune CAR-T space heats up

Last year
Financing
Cell/Gene Tx

Deer­field adds an­oth­er aca­d­e­m­ic part­ner in $130M Wash­ing­ton Uni­ver­si­ty pact

Last year
Deals

Dis­co de­buts with €20M seed round to ad­vance sur­faceome-based plat­form, with sup­port from Ab­b­Vie

Last year
Financing

Mid-stage CNS biotech Al­to Neu­ro­science files for NYSE list­ing

Last year
Financing

Ex­clu­sive: Au­toim­mune CAR-T biotech Kyver­na Ther­a­peu­tics is con­sid­er­ing an IPO next month

Last year
Financing
Cell/Gene Tx

The Bell Labs of biotech: Stu­art Schreiber has bil­lion­aire sup­port for new bio­med­ical in­sti­tute 

Last year
People

Ver­tex founder Joshua Boger on sur­viv­ing down­turns, 'painful' part­ner­ships, and the im­por­tance of cul­ture: #JPM24

Last year
People

Greg Ver­dine’s LifeM­ine eyes the clin­ic next year with T-cell im­muno­sup­pres­sive and an­ti­fun­gal: #JPM24

Last year
R&D

CNS biotech My­robal­an Ther­a­peu­tics rais­es $24M Se­ries A to en­ter the clin­ic

Last year
Financing
China

Ex­clu­sive: Al­pha­bet's Iso­mor­phic inks first phar­ma deals with Eli Lil­ly and No­var­tis for $83M up­front, $2.9B in mile­stones

Last year
Deals
AI

Gene edit­ing com­pa­ny Metageno­mi sub­mits IPO pa­per­work in third planned biotech list­ing of 2024

Last year
Financing
Cell/Gene Tx

Ar­riVent files for IPO, rais­ing funds as it takes PhI­II can­cer drug through tri­al

Last year
Financing

Psy­che­del­ic-as­sist­ed drug de­vel­op­er MAPS PBC nabs $100M, re­names to Lykos Ther­a­peu­tics

Last year
Financing

Feng Zhang's CRISPR start­up Aera shrinks head­count by a quar­ter

Last year
People

Claris rais­es $57M in Se­ries A as it awaits key tri­al read­out on eye drug

Last year
Financing
R&D

Ex­clu­sive: Roger Perl­mut­ter on the biggest prob­lem in Big Phar­ma, leav­ing Mer­ck, and build­ing Eikon

Last year
People
R&D

An­oth­er day, an­oth­er ADC: On­Cusp se­cures $100M Se­ries A from No­vo, Or­biMed and oth­ers to run PhI tri­al

Last year
Financing
China
First page Previous page 20212223242526 Next page Last page
A service from the Financial Times